Wall Street analyst estimates for CAMP4 Therapeutics Corporation (CAMP): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Valuation Ratios
| Price / Book | -362.08 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $351.1M | $365.9M | $363.8M | $366.1M | $308.6M | $295.8M | $294.9M | $350000 | $652000 | $3.5M |
| Cost of Revenue | $207.8M | $215.0M | $216.0M | $222.8M | $186.2M | $174.0M | $185.9M | 0 | 0 | $1.6M |
| Gross Profit | $143.4M | $150.9M | $147.8M | $143.3M | $122.4M | $121.9M | $109.0M | $350000 | $652000 | $1.9M |
| Research & Development | $22.0M | $25.8M | $27.7M | $29.4M | $25.8M | $28.4M | $24.6M | $40.6M | $38.8M | $38.2M |
| Selling, General & Admin | $104.9M | $102.2M | $81.0M | $118.2M | $95.3M | $100.9M | $99.2M | $11.6M | $14.9M | $17.4M |
| Operating Expenses | $142.0M | $142.9M | $120.1M | $160.0M | $125.9M | $134.8M | $133.7M | $52.2M | $53.7M | $53.9M |
| Operating Income | $1.3M | $8.0M | $19.7M | -$16.8M | -$6.8M | -$13.5M | -$24.7M | -$51.9M | -$53.1M | -$52.1M |
| EBITDA | $24.7M | $31.4M | $47.1M | $15.2M | $8.5M | -$2.6M | -$25.1M | -$50.2M | -$51.4M | -$50.4M |
| Interest Expense | $9.9M | $10.3M | $16.7M | $20.1M | $5.8M | $5.2M | $6.3M | 0 | 0 | 0 |
| Pre-tax Income | -$7.0M | $28.7M | $23.9M | -$58.3M | -$20.6M | -$30.1M | -$31.3M | -$49.3M | -$51.8M | -$80.4M |
| Income Tax | -$1.1M | $10.7M | -$1.3M | $20.5M | $561000 | $1.1M | $1.2M | 0 | 0 | 0 |
| Net Income | -$7.2M | $16.6M | $18.4M | -$78.8M | -$56.3M | -$28.0M | -$32.5M | -$49.3M | -$51.8M | -$80.4M |
| EPS | $-0.20 | $0.47 | $0.53 | $-2.35 | $0.00 | $0.00 | $-0.90 | $-4.07 | $-2.66 | $-2.65 |
| EPS (Diluted) | $-0.20 | $0.46 | $0.52 | $-2.34 | $0.00 | $0.00 | $-0.90 | $-4.07 | $-2.66 | $-2.65 |
| Shares Outstanding (Diluted) | $35.9M | $36.1M | $35.3M | $33.7M | $1.5M | $1.5M | $36.1M | $12.1M | $19.5M | $30.4M |
Price
| Price | $3.86 |
| Market Cap | $82M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explore sector: Healthcare · Biotechnology
More sections of CAMP: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks